Azvudine efficacy in reducing mortality in COVID-19 patients
The study suggests that in hospitalized patients with COVID-19, azvudine treatment significantly reduces patient mortality rates in hospitalized COVID-19 infections, wherein the effects are more pronounced in severe and critical patients.
Authors
- Jianing Zhong (ORCID: https://orcid.org/0000-0002-2781-3437)
- Xiaofeng Liu (ORCID: https://orcid.org/0000-0003-3776-8913)
- Rong Li (ORCID: https://orcid.org/0009-0008-6177-2246)
- Zhen Zhong
- Xiaozhong Zhou
- Xian-fa Liu
- Li-cheng Zhou
Institutions
- Gannan Medical University (CN)
- First Affiliated Hospital of Gannan Medical University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1186/s40001-024-02220-9
- Citations
- 5
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.95
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Health Commission of Jiangxi Province
- Gannan Medical University